The Stock Exchange of Thailand (SET) will list Bangkok Genomics Innovation pcl, a leading medical diagnostics service provider utilizing world-class genomic technology, on March 20, 2024 under the ticker symbol “BKGI”. The company has a market capitalization at its initial public offering (IPO) of THB 978 million (approx. USD 27.40 million).
SET Senior Executive Vice President Manpong Senanarong said BKGI will start trading on SET in the Services industry group, Health Care Services sector.
Key Takeaways
- Bangkok Genomics Innovation pcl, a leading medical diagnostics provider, will be listed on the Stock Exchange of Thailand with a market capitalization of approximately USD 27.40 million, offering services such as Non-Invasive Prenatal Testing and genetic screening.
- The company aims to use the funds raised from the IPO to expand its genomic medicine business and promote…
